A-Review on Anticancer Agents: Conventional Drugs and Novel Target Specific Inhibitors
Piyushkumar Sadhu
Oriental Journal Of Chemistry
View PDFchevron_right
Development of anti-cancer drugs
Hui Gan
Discovery medicine
View PDFchevron_right
Comparison of Cytotoxic Activity of Anticancer Drugs against Various Human Tumor Cell Lines Using In Vitro Cell-Based Approach
Frederick Dela Cruz
International journal of biomedical science : IJBS, 2012
View PDFchevron_right
The role of pharmacology in anticancer drug development
Anne-Sophie Govaerts
ADMET and DMPK
View PDFchevron_right
Drug development in oncology: classical cytotoxics and molecularly targeted agents
Martin Gutierrez
British Journal of Clinical Pharmacology, 2006
View PDFchevron_right
Contemporary pre-clinical development of anticancer agents – What are the optimal preclinical models?
Maurizio D'Incalci
European Journal of Cancer, 2009
View PDFchevron_right
Special Issue on “Anticancer Drugs Activity and Underlying Mechanisms”
Domenico Iacopetta
Applied Sciences
View PDFchevron_right
In the search for new anticancer drugs. VII
Jan Lukszo
Journal of Cancer Research and Clinical Oncology, 1984
View PDFchevron_right
Current trends in anticancer drug prototype in vitro pharmacology: bibliometric analysis 2019–2021
Pavel Ershov
2021
View PDFchevron_right
An Insight into Cancer and Anticancer Drugs
Raichel Nivetha
Acta Scientific Medical Sciences
View PDFchevron_right
In Vitro Assessment of Antitumor Potential and Combination Effect of Classical and Molecular-targeted Anticancer Drugs
Hiroshi Sakagami
Anticancer Research, 2019
View PDFchevron_right
Anticancer therapeutics: a brief account on wide refinements
Fiza ur Rehman
2020
View PDFchevron_right
Drug resistance: important criteria for cancer drug development
Pharmaceutical and Biological Evaluations, Chelamalla Radhika
View PDFchevron_right
Assessment of in Vitro and in Vivo Activities in the National Cancer Institute's Anticancer Screen with Respect to Chemical Structure, Target Specificity, and Mechanism of Action
Ruili Huang
Journal of Medicinal Chemistry, 2006
View PDFchevron_right
Recent advances in anticancer drug discovery: A review
Innovative Publication
International Journal of Pharmaceutical Chemistry and Analysis, 2023
View PDFchevron_right
Strategic pre-clinical development of Riminophenazines as resistance circumventing anticancer agents
Dwayne koot
2013
View PDFchevron_right
Novel Anticancer Strategies
Hassan Bousbaa
Pharmaceutics, 2021
View PDFchevron_right
Improving the odds of success in antitumoral drug development using scoring approaches towards heterocyclic scaffolds
Octavian Olaru
Oncology Reports, 2020
View PDFchevron_right
Novel Anticancer Strategies II
Hassan Bousbaa
Pharmaceutics
View PDFchevron_right
A structural analysis of the differential cytotoxicity of chemicals in the NCI60 cancer cell lines
Suman Chakravarti
Bioorganic & Medicinal Chemistry, 2008
View PDFchevron_right
Exploring the novel heterocyclic derivatives as lead molecules for design and development of potent anticancer agents
Iqbal Azad
Journal of Molecular Graphics & Modelling, 2018
View PDFchevron_right
In silico modelling of quantitative structure–activity relationship of multi-target anticancer compounds on k-562 cell line
Stephen Abechi
Network Modeling Analysis in Health Informatics and Bioinformatics, 2018
View PDFchevron_right
Anti-cancer drug characterisation using a human cell line panel representing defined types of drug resistance
Johan Botling
British journal of cancer, 1996
View PDFchevron_right
Recent developments in cancer chemotherapy oriented towards new targets
Thomas Szekeres
Expert Opinion on Therapeutic Targets, 2005
View PDFchevron_right
Anticancer agents targeting signaling molecules and cancer cell environment: challenges for drug development?
Elizabeth Eisenhauer
1999
View PDFchevron_right
Chou JH, Chang TT and Chou TC. Models for Drug Develppment and Drug Resistence. Cancer Handbook, 2nd ed. Alison MR ed-in-chief Jhon Wiley & Son, Ltd, West Sussex, England. Chapter 75, Vol.2, 1027-1042, 2007
Shu-huey Chen, Tai-tsung Chang, Rong-long Chen
View PDFchevron_right
17. New anti cancer agents Recent development in tumor prevention
Ghulam Md Ashraf
View PDFchevron_right
CANCER DRUG DEVELOPMENT
DIPANJAN GOSWAMI
View PDFchevron_right
Semi-mechanistic description of the in-vitro antiproliferative effect of different antitumour agents
Iñaki Trocóniz
Journal of Pharmacy and Pharmacology, 2008
View PDFchevron_right
Anticancer drug development
Felipe Ades, Dimitrios Zardavas
Current Opinion in Oncology, 2014
View PDFchevron_right
Implementation of the NCI-60 Human Tumor Cell Line Panel to Screen 2260 Cancer Drug Combinations to Generate >3 Million Data Points Used to Populate a Large Matrix of Anti-Neoplastic Agent Combinations (ALMANAC) Database
Paul Johnston
2019
View PDFchevron_right
New anticancer agents: recent developments in tumor therapy
Ghazi Damanhouri
Anticancer research, 2012
View PDFchevron_right